In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Perindopril Erbumine Monohydrate Drug Master File in Korea (Perindopril Erbumine Monohydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Perindopril Erbumine Monohydrate. The MFDS reviews the Perindopril Erbumine Monohydrate KDMF as part of the drug registration process and uses the information provided in the Perindopril Erbumine Monohydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Perindopril Erbumine Monohydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Perindopril Erbumine Monohydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Perindopril Erbumine Monohydrate suppliers with KDMF on PharmaCompass.